Article

Blood-Based RNA Biomarkers and Machine Learning Approaches for Alzheimer’s Disease

2026-05-13

Abstract excerpt

Alzheimer's disease (AD), a leading cause of dementia worldwide, is a neurological disorder characterized by progressive cognitive decline. AD is also considered a significant socioeconomic burden. While definitive diagnostic tools such as positron emission tomography (PET) imaging and cerebrospinal fluid (CSF) biomarker analysis offer high sensitivity and specificity, they are limited by high cost, invasiven...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6a350371-846c-5dac-b514-5b0bfb65643a
DOI: 10.20944/preprints202605.0893.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Blood-Based RNA Biomarkers and Machine Learning Approaches for Alzheimer’s DiseaseDOI 10.20944/preprints202605.0893.v1Read

Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read

Blood-based transcriptomic biomarkers are predictive of neurodegeneration rather than Alzheimer’s diseaseSemantic proximity Read

An RNA biomarker panel for the diagnosis of Alzheimer’s disease from whole bloodSemantic proximity Read

Toward an Alzheimer's disease diagnosis via high‐resolution blood gene expressionSemantic proximity Read

Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and PrognosticsSemantic proximity Read

Identification of common molecular biomarker signatures in blood and brain of Alzheimer’s diseaseSemantic proximity Read

Identification of Blood Biomarkers for Alzheimer's Disease Through Computational Prediction and Experimental ValidationSemantic proximity Read

Blood Genome-Wide Transcriptional Profiles Reflect Broad Molecular Impairments and Strong Blood-Brain Links in Alzheimer's DiseaseSemantic proximity Read

Multi-Omics Integration of Transcriptomics and Metabolomics with Machine Learning Uncovers Novel Risk Factors for Alzheimer’s diseaseSemantic proximity Read

Exploratory Single-Cell RNA Sequencing of Peripheral Blood Identifies Candidate Signatures Associated with Alzheimer’s DiseaseSemantic proximity Read

Validation of AclarusDx™, a Blood-Based Transcriptomic Signature for the Diagnosis of Alzheimer's DiseaseSemantic proximity Read

Blood biomarker-based classification study for neurodegenerative diseasesSemantic proximity Read